May 14, 2018
FDA: AuroMedics Pharma recalls two lots of Piperacillin and Tazobactam for Injection
Editor's Note
The Food and Drug Administration (FDA) on May 8 announced the recall by AuroMedics Pharma (Windsor, New Jersey) of two lots of Piperacillin and Tazobactam for Injection, USP 3.375 g in a single-dose vial.
The vials were found to contain particulate matter after reconstitution that was confirmed to be glass.
The recalled lots are PP0317061-A, Exp Aug 2019, and PP9317049-A, Exp Aug 2019.
Free Daily News
- Study: Knee arthritis surgery neither delays nor hastens total replacement
- Study: Reverse total shoulder replacement long-term outcomes similar to traditional surgery
- Wearables could help surgeons maintain healthy posture during lengthy procedures
- Robotic-assisted total knee replacements: Improved outcomes, higher costs
- Analyzing impact of long COVID on cognitive health, surgical outcomes
- Study: Bariatric surgery improves kidney transplant eligibility for patients with obesity
- Premature mortality rates higher for lesbian, bisexual female nurses
- Lit-up landmarks spotlight caretaker contributions for National Nurses Week
- Study: Nurses ideally positioned but not sufficiently educated to combat human trafficking
- State grant helps build healthcare talent pipeline
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging